Using rapid evaluation techniques in breast cancer lymph node biopsies
Application of Rapid On-site Evaluation in Lymph Node Biopsy of Breast Cancer
NA · Yunnan Cancer Hospital · NCT06495736
This study is testing if a quick evaluation method during lymph node biopsies can help doctors get faster and more accurate results for patients with breast cancer.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Sex | Female |
| Sponsor | Yunnan Cancer Hospital (other) |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Kunming, Yunnan) |
| Trial ID | NCT06495736 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of rapid on-site evaluation (ROSE) during lymph node biopsies in patients with breast cancer. The study aims to determine if the ROSE technique can enhance the diagnostic efficiency and accuracy of lymph node assessments. Participants will undergo standard lymph node biopsy procedures, with the ROSE technique applied to the samples for immediate evaluation. The goal is to improve the overall diagnostic process for breast cancer patients.
Who should consider this trial
Good fit: Ideal candidates are patients with pathologically confirmed primary breast cancer who are eligible for surgical treatment.
Not a fit: Patients with a history of surgery on the affected axilla or those who have undergone previous radiotherapy or chemotherapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to quicker and more accurate diagnoses for breast cancer patients, potentially improving treatment outcomes.
How similar studies have performed: While the ROSE technique has been used in other contexts, this specific application in breast cancer lymph node biopsies is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients had pathologically confirmed primary breast cancer * Surgical treatment was available Exclusion Criteria: * Previous history of surgery on the affected axilla, internal breast or chest * Pregnant or breastfeeding patients * Previous radiotherapy or chemotherapy * Complicated history of other tumors
Where this trial is running
Kunming, Yunnan
- Yunnan Cancer Hospital — Kunming, Yunnan, China (RECRUITING)
Study contacts
- Study coordinator: Qi Tang, Doctor's degree
- Email: tangqi@kmmu.edu.cn
- Phone: 13577174366
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Breast Cancer